Davos Alzheimer’s Collaborative and pharmaceutical and diagnostics companies work together on Alzheimer’s disease blood biomarker validation

Written by Emily Scholler

Click here to read the full press release →

Emily Scholler
Previous

Davos Alzheimer's Collaborative launches innovative brain health navigator program for intuitive coordination between patients and providers
Next

US FELLOWSHIP PROGRAM LAUNCHED TO ACCELERATE EARLY DETECTION OF COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE